Velan Capital Investment Management LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Velan Capital Investment Management LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,196,346
+37.9%
6,986,744
+55.3%
5.80%
+19.7%
Q2 2023$5,220,000
-23.2%
4,500,0000.0%4.85%
-16.3%
Q1 2023$6,795,000
+8.7%
4,500,000
+80.0%
5.79%
+4.9%
Q4 2022$6,250,0002,500,0005.52%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders